Evidence map›Paper›PMID 26503011›Full record

ArticleBMC infectious diseases2015

Public health impact of strain specific immunity to Borrelia burgdorferi.

Camilo E Khatchikian, Robert B Nadelman, John Nowakowski, Ira Schwartz, Michael Z Levy, Dustin Brisson, Gary P Wormser

Abstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Development of an mRNA-lipid nanoparticle vaccine against Lyme disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Camilo E KhatchikianEvolution and Ecology of Disease Systems Laboratory, Department of Biology, University of Pennsylvania, Philadelphia, PA, USA. camilok@sas.upenn.edu.
Robert B NadelmanDivision of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY, USA. robert_nadelman@nymc.edu.
John NowakowskiDivision of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY, USA. john_nowakowski@nymc.edu.
Ira SchwartzDepartment of Microbiology and Immunology, New York Medical College, Valhalla, NY, USA. ira_schwartz@nymc.edu.
Michael Z LevyDepartment of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. mzlevy@mail.med.upenn.edu.
Dustin BrissonEvolution and Ecology of Disease Systems Laboratory, Department of Biology, University of Pennsylvania, Philadelphia, PA, USA. dbrisson@sas.upenn.edu.
Gary P WormserDivision of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY, USA. gwormser@nymc.edu.

Funding

DETERMINANTS OF B BURGDORFERI HEMATOGENOUS DISSEMINATIONR01AI045801 · NIAID · NEW YORK MEDICAL COLLEGE · PI SCHWARTZ, IRA S. · 1999 to 2015
$4.9M
NUCLEIC ACID-BASED DIANOSTIC PROBES FOR LYME DISEASER01AR041511 · NIAMS · NEW YORK MEDICAL COLLEGE · PI SCHWARTZ, IRA S. · 1991 to 2009
$4.1M
Phylogeographic dynamics of a vector and pathogen in a natural environmentR01AI097137 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRISSON, DUSTIN · 2012 to 2016
$1.9M
Causes and consequences of ospC variation in Borrelia burgdorferi to Lyme diseaseR01AI076342 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRISSON, DUSTIN · 2008 to 2011
$1.4M
NIAID NIH HHS AI076342NIAID NIH HHS AI097137NIAID NIH HHS AI45801NIAID NIH HHS R01 AI045801NIAID NIH HHS R01 AI076342NIAID NIH HHS R01 AI097137NIAMS NIH HHS AR41511NIAMS NIH HHS R01 AR041511
6 · The paper itself

Abstract

backgroundLyme disease, caused by Borrelia burgdorferi, is the most common tick-borne infection in the United States. Although humans can be infected by at least 16 different strains of B. burgdorferi, the overwhelming majority of infections are due to only four strains. It was recently demonstrated that patients who are treated for early Lyme disease develop immunity to the specific strain of B. burgdorferi that caused their infection. The aim of this study is to estimate the reduction in cases of Lyme disease in the United States that may occur as a result of type specific immunity.

methodsThe analysis was performed based on three analytical models that assessed the effects of type specific immunity. Observational data on the frequency with which different B. burgdorferi strains cause human infection in culture-confirmed patients with an initial episode of erythema migrans diagnosed between 1991 and 2005 in the Northeastern United States were used in the analyses.

resultsAssuming a reinfection rate of 3 % and a total incidence of Lyme disease per year of 300,000, the estimated number of averted cases of Lyme disease per year ranges from 319 to 2378 depending on the duration of type specific immunity and the model used.

conclusionGiven the assumptions of the analyses, this analysis suggests that type specific immunity is likely to have public health significance in the United States.

Indexed as

Borrelia burgdorferiBorrelia burgdorferi GroupHumansIncidenceLyme DiseaseNew YorkPublic HealthUnited States

Identifiers

PMID26503011
PMCPMC4621928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.